Investor Presentaiton slide image

Investor Presentaiton

Robust IP driving the Discovery program Clarity's proprietary SAR Technology platform can be used in conjunction with any number of targeting ligands to create new products and new IP CLARITY PHARMACEUTICALS Broad Patent Portfolio Discovery Engine Platform Protection Granted and new chelator patents used in further developing lead and back-up products Product Protection " " Maintenance of pending applications for potential continuation or divisional filings (on existing important patents) New patents filed on lead and back-up compounds Pipeline Protection New chelator patents used in future discovery products New patents filed on novel treatment regimes for radiopharmaceutical and imaging applications Manufacturing and process protection " " Manufacturing and formulation patents New patents filed on manufacturing processes CLARITY 2014 M Select high value cancer targets Generate and radiolabel compounds (peptides and/or antibodies) 64Cu imaging in tumour models 眼眼 67 Cu efficacy studies in tumour models SAR Technology platform High value clinical candidates: SARTATE™M, SAR-bisPSMA, SAR-Bombesin, etc. 29
View entire presentation